Cho Iksung, Ó Hartaigh Bríain, Gransar Heidi, Valenti Valentina, Lin Fay Y, Achenbach Stephan, Berman Daniel S, Budoff Matthew J, Callister Tracy Q, Al-Mallah Mouaz H, Cademartiri Filippo, Chinnaiyan Kavitha, Chow Benjamin J W, Dunning Allison M, DeLago Augustin, Villines Todd C, Hadamitzky Martin, Hausleiter Joerg, Leipsic Jonathon, Shaw Leslee J, Kaufmann Philipp A, Cury Ricardo C, Feuchtner Gudrun, Kim Yong-Jin, Maffei Erica, Raff Gilbert, Pontone Gianluca, Andreini Daniele, Chang Hyuk-Jae, Min James K
Department of Radiology, NewYork-Presbyterian Hospital and the Weill Cornell Medical College, New York, NY, USA; Division of Cardiology, Severance Cardiovascular Hospital and Severance Biomedical Science Institute, Yonsei University College of Medicine, Yonsei University Health System, Seoul, South Korea.
Department of Radiology, NewYork-Presbyterian Hospital and the Weill Cornell Medical College, New York, NY, USA; Department of Internal Medicine, Section of Geriatrics, Yale School of Medicine, Adler Geriatric Center, New Haven, USA.
Atherosclerosis. 2017 Jul;262:185-190. doi: 10.1016/j.atherosclerosis.2016.12.006. Epub 2016 Dec 3.
Coronary artery calcium (CAC) scoring is a predictor of future adverse clinical events, and a surrogate measure of overall coronary artery plaque burden. Coronary computed tomographic angiography (CCTA) is a contrast-enhanced method that allows for visualization of plaque as well as whether that plaque causes luminal narrowing. To date, the prognosis of individuals with CAC but without stenosis has not been reported. We explored the prevalence of CAC>0 and its prognostic utility for future mortality for patients without luminal narrowing by CCTA.
From 17 sites in 9 countries, we identified patients without known coronary artery disease, who underwent CAC scoring and CCTA, and were followed for >3 years. CCTA was graded for % stenosis according to a modified American Heart Association 16-segment model. We calculated hazard ratios (HR) with 95% confidence intervals (95% CI) for incident mortality and compared risk of death for patients as a function of presence or absence of CAC and presence or absence of luminal narrowing by CCTA.
Among 6656 patients who underwent CCTA and CAC scoring, 399 patients (6.0%) had no coronary luminal narrowing but CAC>0. During a median follow-up of 5.1 years (IQR: 3.9-5.9 years), 456 deaths occurred. Compared to individuals without luminal narrowing or CAC, individuals without luminal narrowing but CAC>0 were older, more likely to be male and had higher rates of diabetes, hypertension, and dyslipidemia. Individuals without luminal narrowing but CAC experienced a 2-fold increased risk of mortality, with increasing risk of mortality with higher CAC score. Following adjustment, incident death persisted (HR, 1.8; 95% CI, 1.1-2.9, p = 0.02) among patients without luminal narrowing but with CAC>0 compared with patients whose CACS = 0. Individuals without luminal narrowing but CAC ≥100 had mortality risks similar to individuals with non-obstructive CAD (0 < stenosis<50%) by CCTA [HR 2.5 (95% CI 1.3-4.9) and 2.2 (95% CI 1.6-3.0), respectively].
Patients without luminal narrowing but with CAC experience greater risk of 5-year mortality. Patients with CAC score ≥100 and no coronary luminal narrowing experience death rates similar to those with non-obstructive CAD.
冠状动脉钙化(CAC)评分是未来不良临床事件的预测指标,也是冠状动脉整体斑块负荷的替代指标。冠状动脉计算机断层扫描血管造影(CCTA)是一种增强对比的方法,可用于观察斑块以及该斑块是否导致管腔狭窄。迄今为止,尚无关于有CAC但无狭窄的个体的预后报道。我们探讨了无管腔狭窄患者中CAC>0的患病率及其对未来死亡率的预后价值。
我们从9个国家的17个研究点中,确定了无已知冠状动脉疾病、接受了CAC评分和CCTA检查且随访时间超过3年的患者。根据改良的美国心脏协会16段模型对CCTA的狭窄百分比进行分级。我们计算了全因死亡率的风险比(HR)及其95%置信区间(95%CI),并比较了有无CAC以及有无CCTA管腔狭窄的患者的死亡风险。
在6656例接受CCTA和CAC评分的患者中,399例(6.0%)无冠状动脉管腔狭窄但CAC>0。在中位随访5.1年(四分位间距:3.9 - 5.9年)期间,发生了4起56例死亡。与无管腔狭窄或CAC的个体相比,无管腔狭窄但CAC>0的个体年龄更大,更可能为男性,糖尿病、高血压和血脂异常的发生率更高。无管腔狭窄但有CAC的个体死亡率增加了2倍,且随着CAC评分升高死亡率风险增加。校正后,无管腔狭窄但CAC>0的患者与CACS = 0的患者相比,全因死亡风险仍然存在(HR,1.8;95%CI,1.1 - 2.9,P = 0.02)。无管腔狭窄但CAC≥100的个体的死亡风险与CCTA显示为非阻塞性CAD(0 <狭窄<50%)的个体相似[HR分别为2.5(95%CI 1.3 - 4.9)和2.2(95%CI 1.6 - 3.0)]。
无管腔狭窄但有CAC的患者5年死亡风险更高。CAC评分≥100且无冠状动脉管腔狭窄的患者的死亡率与非阻塞性CAD患者相似。